What's new

Human medicines European public assessment report (EPAR): Welireg, belzutifan, Status: Authorised

Human medicines European public assessment report (EPAR): Welireg, belzutifan, Status: Authorised

Feb 27, 2025 - 13:57
 0
Human medicines European public assessment report (EPAR): Welireg, belzutifan, Status: Authorised
Human medicines European public assessment report (EPAR): Welireg, belzutifan, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib,...

Next Article

Densely packed spherical zinc deposition by cation buffer strategy enabled high-...

Related Posts

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 67, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0